Pharmacoviligance: farmacovigilancia@kersa.com.gt
Principal Active: SITAGLIPTINA + METFORMINA
Composition: 50/1000 mg – 100/1000 mg – 50/1000 mg – 50/500 mg Presentation: 28 tablets Therapeutical class: Cardiometabolic
Medicine mainly used in: Diabetes type 2
Contraindications: Do not take this medicine if you have hypersensitivity to the active substance or any of the excipients
Administration and dosage: